$VSTM the article below is interesting Gist is that roche paid 75m to buy a drug that will combo with theirs for a phase1 trial in the kras space. Found this little nugget regarding WHY: "RLY-1971 has the potential to serve as a backbone for combination therapy across numerous solid tumors" Hmm...who does that sound like? Oh yeah vstm. Whats that? Vstm is already in p2 in the same space iirc? Just brought on bluebird guy to drive research for p3 and all his contacts and remember brian johnson the merger guru they picked up a while back? Funny huh? Almost like theyre planning for a partnership or a buyout...
  • 13
13 Likes